Managed Healthcare Executive March 25, 2024
Denise Myshko

A new study finds that the use of continuous glucose monitoring helps reduce complications from type 1 diabetes, lowering the risk of developing or progressing diabetic retinopathy.

The use of continuous glucose monitoring by patients with type 1 diabetes was associated with lower odds of developing diabetic retinopathy, according to a study recently published in the JAMA Network Open.

Diabetic retinopathy affects the blood vessels in the retina and can cause vision loss and blindness. The condition can develop in both patients who have type 1 diabetes or type diabetes.

The use of continuous glucose monitoring — devices to automatically estimate blood glucose levels to provide real-time updates throughout the day — has risen. One study, published in January 2024,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Patient / Consumer, Provider, Survey / Study, Technology, Trends, Wearables
Q&A: Bring your own device: How patients own tech is being used in clinical trials
AR and VR Have Potential to Reshape Wearable Tech Landscape
Ultrahuman Opens U.S. Manufacturing Facility for Wearable Rings
The Iyo One earbuds are the latest in wearable AI
Emerging Trends in Pain Management Technologies

Share This Article